Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuko Mitobe
Observed names:
Mitobe, Y.,
Mitobe, Yuko
Institution:
Torii Pharmaceutical Co., Ltd. (Japan)
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
University of Tsukuba,
Japan Pharmaceutical Manufacturers Association,
Torii Pharmaceutical Co., Ltd. (Japan)
ORCID:
0000-0001-8897-8561
Observed ORCID:
0000-0001-8897-8561
OpenAlex ID:
A5007001095
Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies
2009
·
Yuko Mitobe
, Sayaka Ito
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
80
A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice
2006
·
Akane Ishihara
, Akio Kanatani
, et al.
·
Proceedings of the National Academy of Sciences
·
76
Synthesis, Structure−Activity Relationships, and Biological Profiles of a Quinazolinone Class of Histamine H3Receptor Inverse Agonists
2008
·
Tsuyoshi Nagase
, Takashi Mizutani
, et al.
·
Journal of Medicinal Chemistry
·
71
Design, syntheses, and structure–activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4′-piperidin]-1′-yl}benzimidazole derivatives
2008
·
Yoshio Ogino
, Norikazu Ohtake
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
46
Effects of a Novel Y5 Antagonist in Obese Mice: Combination With Food Restriction or Sibutramine
2008
·
Satoshi Mashiko
, Akane Ishihara
, et al.
·
Obesity
·
28
Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor
2009
·
Makoto Ando
, Nagaaki Sato
, et al.
·
Bioorganic & Medicinal Chemistry
·
26
Syntheses and structure–activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1′-cyclohexan]-4′-yl]benzimidazole NPY Y5 receptor antagonists
2008
·
Yoshio Ogino
, Norikazu Ohtake
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
23
Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor
2005
·
Sayaka Ito
, Ryo Yoshimoto
, et al.
·
European Journal of Pharmacology
·
22
Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice
2009
·
Ryuichi Moriya
, Satoshi Mashiko
, et al.
·
Peptides
·
18
Synthesis and Evaluation of Structurally Constrained Quinazolinone Derivatives as Potent and Selective Histamine H3Receptor Inverse Agonists
2008
·
Tsuyoshi Nagase
, Takashi Mizutani
, et al.
·
Journal of Medicinal Chemistry
·
18
State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan
2019
·
Katsuyo Ohashi-Doi
, Kaare Lund
, et al.
·
Biological and Pharmaceutical Bulletin
·
14
PDF
Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1′-cyclohexane]-4′-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist
2009
·
Yuji Haga
, Toshihiro Sakamoto
, et al.
·
Bioorganic & Medicinal Chemistry
·
14
Japanese Cedar Pollen Allergens in Japan
2022
·
Katsuyo Ohashi-Doi
, Daichi Utsumi
, et al.
·
Current Protein and Peptide Science
·
12
Impact of nausea/vomiting on EQ-5D-5L utility scores in patients taking iron preparations for heavy menstrual bleeding or anemia
2023
·
Kyoko Ito
, Yuko Mitobe
, et al.
·
BMC Women s Health
·
11
PDF
Identification of positron emission tomography ligands for NPY Y5 receptors in the brain
2009
·
Hirobumi Takahashi
, Yuji Haga
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
11
Synthesis, structure–activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H3 receptor inverse agonists
2009
·
Takahide Sasaki
, Toshiyuki Takahashi
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
10
The quality of life and work productivity are affected by the presence of nausea/vomiting in patients taking iron preparations for heavy menstrual bleeding or anemia: a population-based cross-sectional survey in Japan
2024
·
Kyoko Ito
, Yuko Mitobe
, et al.
·
BMC Women s Health
·
8
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia
2024
·
Kyoko Ito
, Tadao Akizawa
, et al.
·
Clinical and Experimental Nephrology
·
7
PDF
Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy
2015
·
Yuko Mitobe
, Yasuki Yokomoto
, et al.
·
Regulatory Toxicology and Pharmacology
·
6
[difference Between Standardized Mite Antigen and House Dust Extract in Rush Subcutaneous Immunotherapy for Children].
2019
·
Yuya Tanaka
, Ikuo Okafuji
, et al.
·
PubMed
·
4
Toxicologic Pathology Forum: Current Status on the Use of Animal Models of Human Disease in the Pharmaceutical Industry in Japan in Nonclinical Safety Assessment–Opinion Paper
2019
·
Masayuki Tomohiro
, Takeshi Okabe
, et al.
·
Toxicologic Pathology
·
3
PDF
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
2024
·
Mikio Momoeda
, Kyoko Ito
, et al.
·
International Journal of Hematology
·
2
PDF
Effect of food on iron absorption in patients with iron deficiency anemia treated with ferric citrate hydrate
2025
·
Norio Komatsu
, Kyoko Ito
, et al.
·
International Journal of Hematology
·
1
PDF
Association between serum hepcidin-25 levels and hyporesponsiveness to erythropoiesis-stimulating agents in Japanese patients receiving hemodialysis: a cross-sectional study
2025
·
Ryo Fujikawa
, Nobuo Nagano
, et al.
·
Clinical and Experimental Nephrology
·
1
PDF
Association between Der p 23 and asthma in children sensitized to house dust mite
2020
·
Yuya Tanaka
, Saori Omae
, et al.
·
Journal of Allergy and Clinical Immunology
·
1
PDF
Show more works
View as search
Works count:
38
Citation count:
513
H-index:
12
I10-index:
16
Year
Topic
Type